As far as TGA, FDA, EMA, etc. are concerned,
(and they are the ones that matter), all the
evidence is circumstantial, until we complete
Phase 3 trials to their satisfaction. Then if they
say we need a Phase 4 trial for some reason,
we will have to comply.
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-193
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $106.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.5¢ | 29.5¢ | $152.7K | 501.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16864 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 20426 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |